// App-Quantinova.ai

12022 2014 AHA : Long-Term Clinical Outcomes of Everolimus-Eluting Stents versus Sirolimus-Eluting Stents: Systematic Review and a Meta-Analysis of 14 Randomized Control Trials, Focused on Stent Thrombosis

Researchers

Presenter

  • Hiroki Shiomi

Principal Investigators

  • Takeshi Morimoto

  • Takeshi Kimura

Medical Centers

  • Hyogo College of Medicine, Nishinomiya-shi, Hyogo, Japan

  • Kyoto University Graduate School of Medicine, Kyoto, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary Artery Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

  • Rapacan

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim